Cystic Fibrosis Therapies to Creon DR 36000
Cystic fibrosis therapies are designed to address the underlying genetic causes and symptoms of cystic fibrosis, a hereditary disorder affecting the lungs and digestive system. These therapies aim to improve lung function, manage respiratory infections, and enhance nutrient absorption. Treatments commonly include medications that thin mucus, antibiotics to prevent and treat lung infections, pancreatic enzyme supplements, and CFTR modulators that target the defective protein caused by the genetic mutation.
-
Sale 16%
Original price $ 1,999.95Current price $ 1,685.00Creon DR (Pancrelipase) Capsules 36,000 USP Uniys 100/Bottle (RX)
Creon DR (Pancrelipase) Capsules 36,000 USP is a treatment of exocrine pancreatic insuffciency (EPI) due to conditions such as cystic fibrosis (Cr...
View full details
Cystic fibrosis therapies are designed to address the underlying genetic causes and symptoms of cystic fibrosis, a hereditary disorder affecting the lungs and digestive system. These therapies aim to improve lung function, manage respiratory infections, and enhance nutrient absorption. Treatments commonly include medications that thin mucus, antibiotics to prevent and treat lung infections, pancreatic enzyme supplements, and CFTR modulators that target the defective protein caused by the genetic mutation.